Table 5 Willingness-to-pay amounts in 2002 dollars for health states
From: Values for preventing influenza-related morbidity and vaccine adverse events in children
a. For each health state avoided | ||||
|---|---|---|---|---|
Median | Mean | 5th – 95th percentile | Range (minimum – maximum) | |
Influenza in 1-year old child* | 175 | 469 | 0 – 1500 | 0 – 10,000 |
Influenza in 14-year old child* | 100 | 288 | 0 – 1000 | 0 – 5,000 |
Guillain-Barré Syndrome in 1-year old child | 5,000 | 28,579 | 100 – 100,000 | 10 – 1,000,000 |
Severe allergic reaction in 1-year old child | 400 | 4,968 | 0 – 10,000 | 0 – 200,000 |
b. For risk reductions | ||||
Median | Mean | 5th – 95th percentile | Range (minimum – maximum) | |
Influenza vaccine with no risk of Guillain-Barré Syndrome after vaccination | 100 | 341 | 3 – 2,000 | 0 – 5,000 |
Influenza vaccine with no risk of severe allergic reaction after vaccination | 50 | 223 | 10 – 1,000 | 0 – 5,000 |